SYNVANTAGE

Serial Number 90100048
Registration 7452470
700

Registration Progress

Application Filed
Aug 7, 2020
Under Examination
Jun 1, 2021
Approved for Publication
Jun 1, 2021
Published for Opposition
May 7, 2024
Registered
Jul 23, 2024

Trademark Image

SYNVANTAGE

Basic Information

Serial Number
90100048
Registration Number
7452470
Filing Date
August 7, 2020
Registration Date
July 23, 2024
Published for Opposition
May 7, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 23, 2024
Registration
Registered
Classes
001 005 042 044

Rights Holder

Syngene International Limited

99
Address
Biocon SEZ, Biocon Park, Plot # 2 & 3
Karnataka Bangalore
IN

Ownership History

Syngene International Limited

Original Applicant
99
Karnataka IN

Syngene International Limited

Owner at Publication
99
Karnataka IN

Syngene International Limited

Original Registrant
99
Karnataka IN

Legal Representation

Attorney
Mark A. Watkins

USPTO Deadlines

Next Deadline
1814 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-23)
Due Date
July 23, 2030
Grace Period Ends
January 23, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jul 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 3, 2024 OTHE I CASE RETURNED TO EXAMINATION Loading...
Apr 3, 2024 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Apr 3, 2024 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Apr 1, 2024 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Apr 1, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Mar 27, 2024 ERTI I TEAS RESPONSE TO PETITION INQUIRY LETTER Loading...
Mar 6, 2024 PILM I PETITION INQUIRY LETTER ISSUED Loading...
Mar 5, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Dec 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 4, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 1, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 3, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 1, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 1, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 30, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 30, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 30, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 20, 2022 CORV P REVIEW OF CORRESPONDENCE COMPLETE Loading...
Oct 20, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 30, 2022 44EP I 44(e) PETITION - RECEIVED Loading...
Sep 30, 2022 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Jul 29, 2022 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Jul 20, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 8, 2022 ATRQ I ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Loading...
Jul 8, 2022 APET A ASSIGNED TO PETITION STAFF Loading...
Jul 8, 2022 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 8, 2022 PGEX O PETITION GRANTED - EXTENSION REQUEST FILED Loading...
Jul 8, 2022 PCBG O PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Loading...
Jul 6, 2022 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Jul 5, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 4, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 22, 2022 APET A ASSIGNED TO PETITION STAFF Loading...
Jun 1, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
May 31, 2022 44EP I 44(e) PETITION - RECEIVED Loading...
May 31, 2022 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Dec 2, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 30, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 30, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 30, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 1, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...

Detailed Classifications

Class 001
Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientific, laboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequences, other than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gels, reagents, chemical standards, dyes and trace dyes for electrophoresis, other than for medical or veterinary purposes; preparative electrophoresis reagents, other than for medical or veterinary purposes
Class 005
Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical use, namely, pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergies, ehrlichiosis, ear infection, diabetes, kennel cough, upper respiratory tract infection, coccidiosis, babesiosis, ectoparasites, endoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging
Class 042
Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology, immunopharmaceuticals and vaccines; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity testing for research purposes; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and biological laboratory for research purposes; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, agrochemical pharmaceuticals, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; scientific and technological services, namely, scientific research, development, analysis, testing, and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, gene, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; Laboratory services, namely, imaging core lab services
Class 044
Drug, alcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; pathology services for medical and diagnostic purposes

Classification

International Classes
001 005 042 044